about
Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunctionChronic intestinal pseudo-obstructionNew Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney DiseaseRapidly Progressive DementiaA mutation in the mitochondrial fission gene Dnm1l leads to cardiomyopathyHypergonadotropic hypogonadism, progressive early-onset spinocerebellar ataxia, and late-onset sensorineural hearing loss: case report and literature review.Central nervous system manifestations of mitochondrial disorders.Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.Long-term Developmental Trends of Pediatric Mitochondrial Diseases: The Five Stages of Developmental DeclineSpectrum of genetic changes in patients with non-syndromic hearing impairment and extremely high carrier frequency of 35delG GJB2 mutation in Belarus.SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial functionElectrocardiography as an early cardiac screening test in children with mitochondrial diseaseRisk factors of ocular involvement in children with mitochondrial respiratory chain complex defect.Systematic identification of human mitochondrial disease genes through integrative genomics.The podocyte power-plant disaster and its contribution to glomerulopathy.Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation?Renal mitochondrial cytopathies.Renal involvement in mitochondrial cytopathies.Hereditary skeletal muscle diseases in the horse. A review.Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease.Kearns-Sayre syndrome presenting as isolated growth failure.Comparative analysis of mitochondrial genotype and aging.Estrogen actions on mitochondria--physiological and pathological implications.Identification of G8969>A in mitochondrial ATP6 gene that severely compromises ATP synthase function in a patient with IgA nephropathy.Disrupted mitochondrial function in the Opa3L122P mouse model for Costeff Syndrome impairs skeletal integrity.Modeling mitochondrial encephalomyopathy in Drosophila.The effects of sodium valproate on the renal function of children with epilepsy.Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies.Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.Mitochondrial dysfunction in the pathophysiology of renal diseases.When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis?Mitochondrial injury and dysfunction in hypertension-induced cardiac damage.Mutations in ND subunits of complex I are an important genetic cause of childhood mitochondrial encephalopathies.Autopsy case of the C12orf65 mutation in a patient with signs of mitochondrial dysfunction.How to bake a brain: yeast as a model neuron.Neuroprotection against neuroblastoma cell death induced by depletion of mitochondrial glutathione.The Emerging Role of Mitochondrial Targeting in Kidney Disease.Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction.Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costsA Diagnostic Algorithm for Mitochondrial Disorders in Estonian Children
P2860
Q24294402-27429BAF-F028-4A0C-A15A-0F8157889BC6Q24647826-4B914B24-B4AB-4E79-98A5-3D12A1D7B159Q26739475-A4863CE8-4286-4D7F-B386-6266D9E53507Q28071290-C101A032-4DF0-4583-803D-16FDE0006D8BQ28509163-B627AE36-B26A-4826-A1D5-8870303E2EF5Q30449162-C80677AB-13F7-4B07-902C-2258A31786CFQ31058031-007ECA47-C64B-43F6-8F9C-854FE021ACB2Q33564995-6D67C600-822B-4510-97EF-693F2CF16545Q33694902-D399571F-7896-4845-828C-BC3E8C45466FQ34261785-C71F6A69-DAB8-4FC7-9977-ECD118B323DAQ34272924-730A3736-FF4F-47D7-813B-9AC1AD7B60A8Q34362978-44E47AA8-DDA5-4A2A-BDD2-9B936BF88083Q34494711-42DE3FE1-49D7-40FA-9D2E-539A488D1364Q34508388-000AC285-E3B4-4160-A3A6-819FA6479FB8Q34699773-8F8C5423-9A08-42A9-B956-8BFC8BD423C0Q35006696-8ADA6EF2-9D3C-4A25-A2F2-8B763CE0B0DBQ35137727-42A900D9-7FFB-4BD7-88E9-FE5728F2795CQ35783708-6AA1CAA5-00A3-4927-9872-FE941817D499Q36196368-363ABFC9-8261-4F4B-82C3-4A083AB32B43Q36320982-FC4AC373-60D5-44EA-9F75-34C71D1447F1Q36704799-AB255DB0-70DA-49F5-9E43-FE62C890F3B8Q36969827-345302D7-DE40-44D2-BE35-AFAB50A753C9Q37197561-9A483F6F-8EE4-45EE-B6B1-7CB03C8D2619Q37393858-78CC1A8A-C007-47CF-9ACC-B1303DC58642Q37530214-E67FC41E-CE68-4A94-8FFC-8FDD22EF3371Q37753231-6AA91079-C044-49D5-9440-0A24FC68E130Q38110460-E178F5D1-9964-4465-8A03-B01469D9D062Q38111967-3A3D35EA-3126-41B5-B30B-40A6D807F044Q38114007-60336559-E960-4968-9504-78882B203FBFQ38168664-0C656C71-AA9A-4983-81B6-2AC18D1EBCB7Q38261972-8587B6F6-8223-44B2-BBC7-EE4F4D51DE3BQ38266758-271B761B-4053-43F1-A1DE-DD1F598393FCQ38493565-D5821688-46B5-425D-B48F-9BC7762B4423Q38626524-3435D7F7-BC67-4CB6-A761-F716C6AA5871Q38702072-59C3ABBB-2B7A-4D1D-AC30-ED906409DC9FQ39180955-19B26EBE-0E3B-40EB-8C70-594241497226Q39252634-B4CD9C3D-27AF-4F5E-8138-1403563E14EAQ42057967-56FA1604-020D-4D44-AFB5-DB1D782DA285Q42250279-31881C44-043F-4E1E-864E-6C760196C3A4Q42278529-11363BAE-3731-4E23-9E57-34BDDBCAB96C
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Mitochondriopathies.
@ast
Mitochondriopathies.
@en
type
label
Mitochondriopathies.
@ast
Mitochondriopathies.
@en
prefLabel
Mitochondriopathies.
@ast
Mitochondriopathies.
@en
P2860
P1476
Mitochondriopathies.
@en
P2093
J Finsterer
P2860
P304
P356
10.1046/J.1351-5101.2003.00728.X
P577
2004-03-01T00:00:00Z